Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review

SIMPLE SUMMARY: Moving from the achievements of immune checkpoint inhibitors in metastatic lung cancer, the great promise of immunotherapy in resectable early-stage is to make a disease, often lethal until now for frequent post-surgery relapses, more curable. This review focuses on role of immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Viscardi, Giuseppe, Vitiello, Fabiana, Servetto, Alberto, Gristina, Valerio, Pizzutilo, Elio Gregory, Canciello, Maria Anna, Medusa, Paola Maria, Salomone, Fabio, Di Guida, Gaetano, Mollica, Mariano, Aronne, Luigi, Scaramuzzi, Roberto, Napolitano, Filomena, Battiloro, Ciro, Caputo, Francesca, Gilli, Marina, Totaro, Giuseppe, Curcio, Carlo, Rocco, Danilo, Montesarchio, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735901/
https://www.ncbi.nlm.nih.gov/pubmed/36497292
http://dx.doi.org/10.3390/cancers14235810

Ejemplares similares

Ejemplares similares